Loading...
•
Dec 31, 2023
Humana Q4 2023 Earnings Report
Reported a GAAP loss per share of $4.42 and an adjusted loss per share of $0.11 for Q4 2023, reflecting increased Medicare Advantage medical cost trends.
Key Takeaways
Humana reported a net loss per share of $4.42 on a GAAP basis and an adjusted loss per share of $0.11 for the fourth quarter of 2023. The results were impacted by rising Medicare Advantage medical costs. The company provided initial full-year 2024 EPS guidance of approximately $14.87 on a GAAP basis and approximately $16.00 on an adjusted basis.
Reports 4Q23 loss per share of $4.42 on a GAAP basis, Adjusted loss per share of $0.11; reports FY 2023 earnings per share (EPS) of $20.00 on a GAAP basis, $26.09 on an Adjusted basis
4Q23 results reflect additional increase in Medicare Advantage medical cost trends, driven by higher than anticipated inpatient utilization, primarily for the months of November and December, and a further increase in non-inpatient trends
Announces initial FY 2024 EPS guidance of 'approximately $14.87' on a GAAP basis, 'approximately $16.00' on an Adjusted basis; assumes the higher Medicare Advantage medical costs experienced in 4Q23 persist throughout 2024
Affirms 2024 individual Medicare Advantage annual membership growth of approximately 100,000 or 1.8 percent
Revenue by Segment
Forward Guidance
Humana provided its initial GAAP and Adjusted EPS guidance for the year ending December 31, 2024 (FY 2024).
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...